Drug Shortage Report for ACT TERBINAFINE

Last updated on 2021-10-14 History
Report ID 111874
Drug Identification Number 02254727
Brand name ACT TERBINAFINE
Common or Proper name TERBINAFINE 250MG TABLET
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) TERBINAFINE
Strength(s) 250MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30
ATC code D01BA
ATC description ANTIFUNGALS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-04-08
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2021-10-14
Company comments Item is under review to be discontinued - Transitioned
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v30 2021-10-14 French Compare
v29 2021-10-14 English Compare
v28 2021-09-02 French Compare
v27 2021-09-02 English Compare
v26 2021-08-27 French Compare
v25 2021-08-27 English Compare
v24 2021-06-17 French Compare
v23 2021-06-17 English Compare
v22 2021-06-03 French Compare
v21 2021-06-03 English Compare
v20 2021-05-20 French Compare
v19 2021-05-20 English Compare
v18 2021-05-06 French Compare
v17 2021-05-06 English Compare
v16 2021-05-06 French Compare
v15 2021-05-06 English Compare
v14 2021-04-08 French Compare
v13 2021-04-08 English Compare
v12 2021-02-25 French Compare
v11 2021-02-25 English Compare

Showing 1 to 20 of 30